Organization Overview
Historical Acquisition Tree
Alternative names
Key: Lundbeck (5) Acquired (2)
carbamazepine (tegretol) (2016)
clobazam (onfi) (2011 NDA)
dimercaprol (NDA)
droxidopa (northera) (2014)
eptinezumab (Vyepti) (2020)
stanozolol (winstrol) (1962 NDA)
vigabatrin (sabril) (2009 NDA)
Key: Lundbeck (26) Acquired (4)
brexpiprazole (rexulti) (28 trials)
clonazepam (klonopin) (2 trials)
desvenlafaxine (pristiq) (1 trial)
droxidopa (northera) (23 trials)
escitalopram (lexapro) (38 trials)
fremanezumab (Ajovy) (1 trial)
frovatriptan (frova) (1 trial)
gabapentin (neurontin) (1 trial)
agomelatine (Valdoxan) (1 trial)
aripiprazole (abilify) (11 trials)
bendamustine (treanda) (1 trial)
bupropion (wellbutrin) (3 trials)
Key: Lundbeck (23) Acquired (2)
[benzyl-7-14c]-idalopirdine (1 trial)
[ethyl-1-14c]-idalopirdine (1 trial)
flupentixol (Depixol) (3 trials)
Acute Coronary Syndrome (Phase 4)
Aggression (Phase 4)
Alcohol Drinking (Phase 3)
Alcoholism (Phase 4)
Alzheimer Disease (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 3)
Anxiety Disorders (Phase 4)
Aphasia (Phase 4)
Aphasia, Primary Progressive (Phase 3)
Ascites (Phase 4)
Ataxia (Phase 2)
Atrophy (Phase 4)
Autism Spectrum Disorder (Phase 3)
Autistic Disorder (Phase 3)
Bipolar Disorder (Phase 4)
Body Weight Changes (Phase 3)
Central Nervous System Diseases (Phase 1)
Cerebellar Ataxia (Phase 2)
Cerebral Infarction (Phase 2)
Child Development Disorders, Pervasive (Phase 3)
Cluster Headache (Phase 3)
Cognition Disorders (Phase 3)
Cognitive Dysfunction (Phase 3)
Compulsive Behavior (Phase 4)
Compulsive Personality Disorder (Phase 4)
Conduct Disorder (Phase 1)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Dementia (Phase 4)
Dementia, Vascular (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 4)
Disease (Phase 4)
Drug Resistant Epilepsy (Phase 4)
Dyssomnias (Phase 3)
Epilepsia Partialis Continua (Phase 3)
Epilepsies, Myoclonic (Phase 3)
Epilepsies, Partial (Phase 4)
Epilepsy (Phase 4)
Epilepsy, Generalized (Phase 3)
Fatigue (Phase 4)
Fibrosis (Phase 4)
Friedreich Ataxia (Phase 2)
Frontotemporal Dementia (Phase 3)
Headache (Phase 3)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Huntington Disease (Phase 4)
Hyperalgesia (Phase 2)
Hyperkinesis (Phase 2)
Hypotension (Phase 4)
Hypotension, Orthostatic (Phase 4)
Impulsive Behavior (Phase 4)
Ischemia (Phase 2)
Lennox Gastaut Syndrome (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Lewy Body Disease (Phase 4)
Liver Cirrhosis (Phase 4)
Liver Cirrhosis, Alcoholic (Phase 4)
Liver Diseases (Phase 1)
Lymphoma (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Mental Disorders (Phase 3)
Migraine Disorders (Phase 3)
Mood Disorders (Phase 3)
Motor Neuron Disease (Phase 3)
Multiple Sclerosis (Phase 3)
Multiple System Atrophy (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nervous System Diseases (Phase 3)
Neurobehavioral Manifestations (Phase 4)
Obsessive-Compulsive Disorder (Phase 4)
Osteoarthritis (Phase 2)
Pain, Postoperative (Phase 4)
Panic Disorder (Phase 4)
Parasomnias (Phase 3)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 2)
Phobia, Social (Phase 4)
Pick Disease of the Brain (Phase 3)
Polyneuropathies (Phase 4)
Postoperative Nausea and Vomiting (Phase 4)
Preleukemia (Phase 2)
Psychomotor Agitation (Phase 3)
Psychotic Disorders (Phase 3)
Recurrence (Phase 3)
Renal Insufficiency (Phase 1)
Schizophrenia (Phase 4)
Sclerosis (Phase 3)
Seizures (Phase 4)
Shy-Drager Syndrome (Phase 2)
Sleep Wake Disorders (Phase 3)
Spasm (Phase 4)
Spasms, Infantile (Phase 4)
Stress Disorders, Post-Traumatic (Phase 3)
Stress Disorders, Traumatic (Phase 3)
Stroke (Phase 3)
Supranuclear Palsy, Progressive (Phase 2)
Syncope (Phase 2)
Syncope, Vasovagal (Phase 2)
Syndrome (Phase 4)
Tachycardia (Phase 2)
Vascular Diseases (Phase 4)
Vomiting (Phase 4)